Tezcat Biosciences

A profile piece about Tezcat Biosciences was recently published in Nature! Take a look to learn more about how Tezcat utilizes protein scavenging (macropinocytosis) to target RAS-activated cancers and other diseases. Special thanks to Springer Nature Group's editorial team and contractors: Elie Dolgin, Ariana Drehsler, and Ffion Cleverley for the content and to the Merck Group for financially supporting the publication of this profile piece. #Curious2024 #TheSpinoffPrize #RAS https://lnkd.in/eEMif4qf

Day 1 done at the #curiousfutureinsight conference hosted by our valued partner Merck Group. Huge congratulations to Ulrich Betz and the team for a successful opening day! Once again over-delivering on a promise! #SpinoffPrize slam completed: massive kudos to Digistain® SalivaDirect, Inc. Tezcat Biosciences and Trince for showstopping pitches! All winners in their own right. I don’t envy the judges! Watch this space for the winner announcement tomorrow! If you’re at the conference, come and stop by the booth and have a chat!

We are excited to announce that Tezcat Biosciences was selected as one of four finalists for Nature Portfolio's The Spinoff Prize, in partnership with Merck KGaA, Darmstadt, Germany. Craig Ramirez, Ph.D. will be participating at the pitch slam finals at #Curious2024 Future Insight e.V. Conference in Mainz, Germany on July 10th. We can't wait for the event and learning about all the other great science happening around the world! https://lnkd.in/eKCxDeEr

Digistain®, SalivaDirect, Inc., Trince and Tezcat Biosciences have made it to the final of the #SpinoffPrize 2024 for turning high-quality scientific research into real-world solutions. Find out who wins the €30,000 prize at Future Insight e.V.. Learn more: https://lnkd.in/gaP2D8EC

Listen to the BioLabs b.empowered podcast episode featuring Craig Ramirez, Ph.D., CEO of our resident company Tezcat Biosciences which is a pre-clinical therapeutics company spun out of NYU Langone Health. Discover how winning a Golden Ticket has accelerated Tezcat Biosciences's #startup journey by providing invaluable lab space and resources. Listen to the full episode here: https://lnkd.in/eWThDHRR

On Monday, TOV and Biolabs@NYULangone co-hosted the inaugural Investor and Innovator Exchange, which brought together visionary founders, early-stage investors, and key industry stakeholders to foster meaningful connections, explore investment opportunities, and drive transformative collaborations. We want to say thank you to everyone who attended and made the event such a success. We heard pitches from 19 innovative startups during the event, including four NYU spinouts (Tezcat Biosciences, Omios Biologics, Regenosine, and Vital Audio Inc | Techstars 23). Congratulations to NYU startup Tezcat Biosciences, awarded the Launchpad Award, designed to propel an early-stage life sciences company and includes six months of free bench or desk space at Biolabs@NYULangone to accelerate their research and growth. Congratulations to Pyrojas for being awarded the Breakthrough Innovation Award which celebrates the most groundbreaking innovation. Thank you to Michelle Ross of StemPoint Capital LP for the engaging fireside chat which highlighted the current challenges facing #biotech as well as the strategic execution and macro tailwinds needed to climb out of the valley. A heartfelt thank you to our sponsors New York City Economic Development Corporation, Safety Partners, Inc., McDermott Will & Emery, Thermo Fisher Scientific, MilliporeSigma, and STEMCELL Technologies, whose support made this event possible. Finally, thank you to Dr. Glennis Mehra and the amazing team at Biolabs@NYULangone for partnering with us on this event. We look forward to hosting the next one soon! #startups #innovation #nyuinnovation #lifesciences #investors #innovators

We were selected to present our unique therapeutic approach earlier this week at the Investor and Innovator Exchange hosted by NYU Technology Opportunities & Ventures and Biolabs@NYULangone. We are extremely grateful to have been awarded the Launchpad Award, which will provide free bench space to keep our momentum in the New York City ecosystem. A shout-out to Dr. Glennis Mehra and Veena Dinesh for bringing together such high caliber companies to this event, we had a great time networking with all!   #Tezcat #BioLabs #NYU #NYULH

Last week at #BIO2024, BioLabs’ CFO John Freeman CPA, MST, CGMA hosted a conversation with our CEO Craig Ramirez, Ph.D. to discuss developing first-in-class therapeutics. This chat was part of the BioLabs Podcast Series entitled b.empowered. To see what Craig had to say, check out the YouTube channel with the video: https://lnkd.in/eUB3kpXf #Tezcat #BioLabs

#BIO2024 - DAY 2 in San Diego - Get ready for another exhilarating day of connection, engagement, and empowerment! This morning, we started off the day with a "Vital" breakfast at BioLabs San Diego and commemorated the Launch of the BARDA Acceleration Network's Therapeutics and Vaccine Hub (VITAL – A BARDA BAN Hub). A huge thank you to everyone who joined us, either in person or virtually. As BIO2024 reopens its doors, our team eagerly awaits your visit at our booth #1110. We have curated an exciting lineup of activities for you throughout the day. Participate in our BioLabs Bingo b.connected, and expand your network by reaching out to our extended community. Don't miss the BIO Exhibition Reception later today - swing by our booth, say Hello, grab a bingo card, and join in the fun for a chance to win some awesome prizes. From 1 PM to 3 PM, we're thrilled to host live podcast recording sessions at our booth, featuring insightful conversations with industry leaders such as Mary Larkin, Manbir Singh, Ashim Subedee from BARDA Accelerator Network, Chloé Leprêtre and Irene Blat, PhD from Servier Pharmaceuticals, and Andrew D. Hauser and Craig Ramirez, Ph.D. from Tezcat Biosciences. Join us in person to witness these talks live, or stay tuned to catch them in the upcoming days. Let's make Day 2 of #BIO2024 another to remember! 🌟 #BioLabsatBio #EmpoweringInnovationWorldwide #BiotechLeadership #NetworkingOpportunities Biotechnology Innovation Organization

Headed to #BIO2024? The NIH SEED is excited to sponsor 45 innovative, peer-reviewed companies with non-dilutive funding. Swing by the NIH booth (825) to learn more! AVM Biotechnology, Samy Hamdouche of Circumvent, Fabio Tucci of Epigen Biosciences, Inc., Jeff Liter Luminary Therapeutics, Inc, Dominique Lessard, Ph.D. of NeuCyte, Elena Molokanova, PhD of NeurANO Bioscience, Athan Kuliopulos of OASIS PHARMACEUTICALS LIMITED, Janak Padia of PRIMETIME LIFE SCIENCES, LLC, John Harkness, Ph.D. of Rewire AI, Jonathan Northrup of Stingray Therapeutics, Brian Kay of Tango Biosciences, Inc., Craig Ramirez, Ph.D. of Tezcat Biosciences, Samuel Chen of Truly Technologies, and David Mead of Terra Bioforge